Explore how surveyed providers perceive current and emerging therapies in the atopic dermatitis.
Gianna Melendez, MS, Spherix Global Insights
Advertisement
Articles by Gianna Melendez, MS, Spherix Global Insights
Spherix Global Insights recently delved into the efficacy, patient quality of life, and symptom management of adalimumab vs secukinumab.
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Dermatology Times
1
Top 5 Articles of the Month: June 2026
2
MoonLake Reports Positive 52-Week Phase 3 Data for Sonelokimab in Hidradenitis Suppurativa
3
Zasocitinib Achieves Higher PASI 100 Rates Than Deucravacitinib at Week 16
4
Upadacitinib Receives Positive CHMP Opinion for Severe Alopecia Areata
5